Clinical Trials · NCT02883595
Efficacy of Thymosin Alpha 1 on Improving Monocyte Function for Sepsis
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Sun Yat-sen University
- Enrollment
- 20
- Start date
- Mar 2016
- Locations
- 1 site, China
- Primary endpoint
- Ta 1 improving immune function of monocyte for sepsis, used by flow cytometric to measure phagocytosis(CD11b, CD64), antigen presenting(HLA-DR, CD86 and PD-L1), and apoptosis(active caspase 3) on monocyte,